Pancreatic Cancer Research

ResearcherIncyte (United States)No recent work listed

Fitzroy Dawkins

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5110186855. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
3
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2013: 1 trial · 2014: 2 trials · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 1

  1. Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase… Co-author DOI 10.1007/s10637-018-0580-2↗

Trials 3

  1. Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) Study director NCT02117479↗
  2. A Study of Ruxolitinib in Pancreatic Cancer Patients Study director NCT02119663↗
  3. An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors Study director NCT01822756↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashwin Reddy Sama · 1 shared paper, 2018 · strength 0.07
  2. Eileen Mary O'Reilly · 1 shared paper, 2018 · strength 0.07
  3. Herbert I. Hurwitz · 1 shared paper, 2018 · strength 0.07
  4. Chris Verslype · 1 shared paper, 2018 · strength 0.07
  5. Manuel M. Hidalgo · 1 shared paper, 2018 · strength 0.07
  6. Chung‐Pin Li · 1 shared paper, 2018 · strength 0.07
  7. Edward W. Greeno · 1 shared paper, 2018 · strength 0.07
  8. Vaibhav Sahai · 1 shared paper, 2018 · strength 0.07
  9. Johanna C. Bendell · 1 shared paper, 2018 · strength 0.07
  10. Kenneth H. Yu · 1 shared paper, 2018 · strength 0.07
  11. Eric Van Cutsem · 1 shared paper, 2018 · strength 0.07
  12. Teresa Mercade Macarulla · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.